Active Surveillance in Low Risk Prostate Cancer: What the Long Term Data Shows
Placeholder entry used to build out the Popular Topics filter.
-
-
How a Common Amino Acid Could Help the Immune System Fight Cancer
New research from Rockefeller University shows that arginine, an inexpensive and widely available amino acid, may help the immune system detect cancer cells and fight viral infections by restoring production of a key immune signaling protein.
-
The PACIFIC Trial: How One Study Changed the Standard of Care for Lung Cancer
The PACIFIC trial demonstrated that durvalumab immunotherapy after chemoradiation significantly improves survival in unresectable stage III NSCLC, permanently reshaping how oncologists treat locally advanced lung cancer.
-
FLASH Radiation Therapy: Ultra-High Dose Rates and the Promise of Reduced Side Effects
FLASH radiation delivers treatment at dose rates hundreds of times faster than conventional therapy, and early evidence suggests it may spare healthy tissue while maintaining tumor control, a potentially transformative shift in radiation oncology.
-
Proton Therapy in Pediatric CNS Tumors: Long-Term Outcomes Data
Decades of outcomes data from St. Jude Children’s Research Hospital and Massachusetts General Hospital show that proton therapy significantly reduces neurocognitive late effects, hearing loss, and endocrine dysfunction in children treated for brain tumors.
-
Proton Therapy for Brain Tumors: How Pediatric Outcomes Are Reshaping Adult Care
Decades of evidence showing proton therapy’s ability to protect developing brains in children with cancer are now driving a reassessment of how we treat adult brain tumors, with profound implications for quality of life.
-
CAR-T Cell Therapy Moves Beyond Blood Cancers: What Solid Tumor Patients Should Know
CAR-T cell therapy transformed outcomes in leukemia and lymphoma. Now researchers are working to extend that success to solid tumors, and the progress, while real, reveals the complexity of what lies ahead.
-
RADCOMP Trial: Proton vs. Photon Therapy for Breast Cancer, What the Results Mean
The RADCOMP trial is the largest randomized study comparing proton and conventional radiation for breast cancer. Here is what the findings mean for patients.